slotkoers
Korea S.E.
00:00:00 29-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
14.890
KRW
|
+2,69%
|
|
+1,99%
|
+1,29%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
69.223
|
50.663
|
69.223
|
85.999
|
41.515
|
87.278
|
Bedrijfswaarde
1 |
67.781
|
54.775
|
76.304
|
88.281
|
48.469
|
93.613
|
K/w-verhouding
|
-9,65
x
|
-7,62
x
|
-28,1
x
|
-47,5
x
|
-6,69
x
|
-9,22
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
16,8
x
|
8,07
x
|
8,13
x
|
8,38
x
|
4,79
x
|
15,6
x
|
Bedrijfswaarde/omzet
|
16,5
x
|
8,73
x
|
8,96
x
|
8,6
x
|
5,6
x
|
16,7
x
|
Bedrijfswaarde/EBITDA
|
-17,8
x
|
-24,7
x
|
58,1
x
|
37,6
x
|
-35,1
x
|
-24,3
x
|
Bedrijfswaarde/FCF
|
-7,24
x
|
-12,3
x
|
84,6
x
|
-40,3
x
|
-13,4
x
|
-48,5
x
|
FCF Yield
|
-13,8%
|
-8,13%
|
1,18%
|
-2,48%
|
-7,45%
|
-2,06%
|
Price to Book
|
3,24
x
|
3,38
x
|
5,65
x
|
4,39
x
|
3,1
x
|
8,3
x
|
Aantal aandelen (in duizenden)
|
5.016
|
5.016
|
5.016
|
5.603
|
5.603
|
5.937
|
Referentieprijs
2 |
13.800
|
10.100
|
13.800
|
15.350
|
7.410
|
14.700
|
Datum van publicatie
|
31-12-19
|
29-02-20
|
01-03-21
|
01-03-22
|
01-03-23
|
29-02-24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
4.114
|
6.277
|
8.516
|
10.267
|
8.662
|
5.611
|
EBITDA
1 |
-3.813
|
-2.214
|
1.313
|
2.346
|
-1.381
|
-3.849
|
Bedrijfsresultaat (EBIT)
1 |
-5.151
|
-4.260
|
-1.047
|
-321,4
|
-4.325
|
-6.717
|
Operationele Marge
|
-125,2%
|
-67,87%
|
-12,29%
|
-3,13%
|
-49,93%
|
-119,71%
|
Resultaat voor belastingen (EBT)
1 |
-8.320
|
-6.645
|
-2.462
|
-1.690
|
-6.205
|
-9.079
|
Nettowinst (verlies)
1 |
-7.164
|
-6.645
|
-2.462
|
-1.690
|
-6.205
|
-9.079
|
Nettomarge
|
-174,12%
|
-105,86%
|
-28,91%
|
-16,46%
|
-71,63%
|
-161,82%
|
WPA
2 |
-1.430
|
-1.325
|
-490,8
|
-323,4
|
-1.107
|
-1.595
|
Free Cash Flow
1 |
-9.360
|
-4.456
|
902,4
|
-2.192
|
-3.611
|
-1.929
|
FCF-marge
|
-227,5%
|
-70,98%
|
10,6%
|
-21,35%
|
-41,69%
|
-34,39%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
68,71%
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
31-12-19
|
29-02-20
|
01-03-21
|
01-03-22
|
01-03-23
|
29-02-24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
-
|
4.112
|
7.081
|
2.281
|
6.954
|
6.335
|
Nettokaspositie
1 |
1.442
|
-
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
-
|
-1,857
x
|
5,392
x
|
0,9726
x
|
-5,035
x
|
-1,646
x
|
Free Cash Flow
1 |
-9.360
|
-4.456
|
902
|
-2.192
|
-3.611
|
-1.929
|
ROE (netto-inkomsten/eigen vermogen)
|
-31,6%
|
-36,5%
|
-18,1%
|
-10,6%
|
-37,6%
|
-75,9%
|
ROA (netto-inkomsten/totale activa)
|
-10,6%
|
-8,05%
|
-2,11%
|
-0,63%
|
-9,27%
|
-17,9%
|
Totale activa
1 |
67.713
|
82.548
|
116.604
|
267.770
|
66.916
|
50.699
|
Nettoactief per aandeel
2 |
4.265
|
2.989
|
2.441
|
3.499
|
2.391
|
1.772
|
Cashflow per aandeel
2 |
296,0
|
153,0
|
218,0
|
221,0
|
85,70
|
171,0
|
Capex
1 |
9.266
|
3.032
|
482
|
838
|
1.552
|
127
|
Capex/omzet
|
225,22%
|
48,31%
|
5,67%
|
8,16%
|
17,92%
|
2,26%
|
Datum van publicatie
|
31-12-19
|
29-02-20
|
01-03-21
|
01-03-22
|
01-03-23
|
29-02-24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| +1,29% | 64,07 mln. | | +39,22% | 727 mld. | | +30,57% | 592 mld. | | -7,85% | 347 mld. | | +15,48% | 319 mld. | | -0,12% | 274 mld. | | +12,55% | 238 mld. | | +6,65% | 204 mld. | | -6,09% | 203 mld. | | -3,37% | 160 mld. |
Farmaceutische producten - Andere
|